Crossmark

Beneficio del empleo precoz de la oxigenoterapia nasal de alto flujo (ONAF) en pacientes con neumonía por SARS-CoV-2

Crossref DOI link: https://doi.org/10.1016/j.medcli.2021.05.015

Published Print: 2022-06

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

García-Pereña, Laura

Ramos Sesma, Violeta

Tornero Divieso, María Lucía

Lluna Carrascosa, Alfonso

Velasco Fuentes, Sara

Parra-Ruiz, Jorge
License Information

Text and Data Mining valid from 2022-06-01

stm-asf valid from 2022-06-01

stm-asf valid from 2022-06-01

stm-asf valid from 2022-06-01

stm-asf valid from 2022-06-01

stm-asf valid from 2022-06-01
More Information

This article is maintained by: Elsevier

Article Title: Beneficio del empleo precoz de la oxigenoterapia nasal de alto flujo (ONAF) en pacientes con neumonía por SARS-CoV-2

Journal Title: Medicina Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcli.2021.05.015

Content Type: simple-article

Copyright: © 2021 Elsevier España, S.L.U. All rights reserved.